Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial.

Moore, A M

Gefitinib in patients with chemo-sensitive and chemo-refractory relapsed small cell cancers: a Hoosier Oncology Group phase II trial. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Apr 2006 - 93-7 p. digital

Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't

0169-5002

10.1016/j.lungcan.2005.12.002 doi


Aged
Antimetabolites, Antineoplastic--therapeutic use
Carcinoma, Small Cell--drug therapy
Drug Resistance, Neoplasm
Female
Gefitinib
Humans
Lung Neoplasms--drug therapy
Male
Maximum Tolerated Dose
Middle Aged
Neoplasm Recurrence, Local
Quinazolines--therapeutic use
Survival Rate
Treatment Outcome